-
Health Economic Modeling in R: A Hands-on Introduction
Sep 28, 2025, 04:48 -
Developing Decision-Grade Real-World Evidence
Sep 28, 2025, 04:48 -
Risk-Sharing/Performance-Based Arrangements in Developing Countries
Sep 28, 2025, 04:48 -
Beyond Good Intentions: Keeping Patient-Centricity Patient-Centric
Sep 28, 2025, 01:13 -
Generative AI: Driving the Next Era of Evidence-Based Medicine
Sep 28, 2025, 01:06 -
What’s Your Health Worth? Contingent Valuation and Discrete Choice Approaches to Assigning Monetary Values to Health Benefits
Sep 27, 2025, 22:04 -
Taste of Scotland
Sep 25, 2025, 16:01 -
Drug Pricing in Theory and in Practice: Value in Health Showcase
Sep 24, 2025, 13:15 -
Prompt Engineering for HEOR: Practical Skills and Use Cases for HEOR Professionals
Sep 22, 2025, 19:50 -
Using LLMs to Simplify Real-World Evidence Research
Sep 22, 2025, 19:50 -
Budget Impact Analysis II: Practical Steps to Building a BIA and Enhanced Applications
Sep 22, 2025, 19:50 -
Valuation of Innovative Drugs
Sep 22, 2025, 19:49 -
Advanced Patient-Reported Outcomes
Sep 22, 2025, 19:47 -
Reimbursement Systems for Pharmaceuticals in Europe
Sep 22, 2025, 19:47 -
HEOR Impact Cases Poster Tour
Sep 22, 2025, 18:00 -
Plenary Session: Special Remarks and Leadership Reports
Sep 22, 2025, 16:24 -
What Is Your Estimand? Navigating Conditional and Marginal Effects in Cost-Effectiveness Modeling
Sep 22, 2025, 16:24 -
Patient Preferences in Clinical Trials and HTA
Sep 22, 2025, 16:24 -
Delay in Patients’ Access Is the Price of Misalignment: Why Evidence Must Speak Also the Language of Payers and Patients
Sep 22, 2025, 16:24 -
Measuring the Social and Environmental Impacts of Innovative Treatments
Sep 22, 2025, 16:24